San Nicola alla Strada, Italy

Menotti Ruvo

This inventor holds 1 USPTO granted patent. Top assignee: Anbition S.r.l.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Menotti Ruvo. Retrieved from https://idiyas.com/inventor/menotti-ruvo-lty3rbrv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Menotti Ruvo: Innovator in Peptide Research

Introduction

Menotti Ruvo is a distinguished inventor based in San Nicola alla Strada, Italy. He has made significant contributions to the field of medical research, particularly in the area of peptides and their applications in treating various pathologies.

Latest Patents

Menotti Ruvo holds a patent for "Peptides and medical uses thereof." This invention relates to peptides, a composition comprising said peptides, and their use as inhibitors of angiogenesis and/or neoangiogenesis. The patent emphasizes the application of these peptides and compositions for treating conditions associated with improper angiogenesis and/or neoangiogenesis, specifically referencing VEGFR1-related issues.

Career Highlights

Throughout his career, Menotti Ruvo has been associated with Anbition S.r.l., where he has focused on innovative research and development in peptide technology. His work has the potential to impact various medical fields, particularly in therapies aimed at regulating blood vessel formation.

Collaborations

Menotti collaborates with notable colleagues, including Davide Rosiello and Sandro De Falco. Their combined expertise enhances the research and development efforts at Anbition S.r.l., fostering an environment of innovation and discovery.

Conclusion

Menotti Ruvo's contributions to peptide research exemplify the importance of innovation in medical science. His patent on peptides as inhibitors of angiogenesis showcases his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…